Surgery is the crucial modality of management in the multidisciplinary care of breast cancer. Without surgery the outcome of treatment is complicated and sub-optimal. The oncologists face dilemma when patient refuse for surgery or not operable due to patients medical condition. Here we describe two post-menopausal women with operable breast cancers those refused surgery. We managed these patien...

Intraoperative radiotherapy (IORT) consists of an accelerated, single-dose, partial breast irradiation, performed immediately after breast conservative surgery. In the present study, we report the results of our feasibility protocol study using IORT between 2005 and 2009. We analyzed the data from a single-center, open, non-randomized, prospective pilot study including patients who underwent br...

Breast chondrosarcoma is a rare sarcoma that mainly occurs in females >50 years old. To the best of our knowledge, only 16 cases were reported in the literature prior to 2013 and all patients were surgically treated by mastectomy, with or without lymphadenectomy, which was occasionally preceded by neoadjuvant chemotherapy. However, the literature does not report the benefit of mastectomy compar...

fibroadenoma is the most common benign mass of breast in females 20-50 years of age. juvenile fibroadenoma accounts for only 4% of total fibroadenomas. moreover, the incidence of giant juvenile fibroadenoma is found to be only 0.5% of all fibroadenomas. a 15-year-old woman at the 12th week of gestation was referred to the shahid sadoughi hospital, yazd, iran because of a mass in the right breas...

background combined procedures involving elective breast surgery at the time of abdominoplasty are frequently performed procedures in aesthetic plastic surgery. while found to be safe outpatient procedures, many surgeons elect to perform combined abdominoplasty/breast surgery as inpatient surgery. this study was performed to explore the practice of performing the combined procedure as an inpati...

BACKGROUND To assess the efficacy of primary single-agent epirubicin (120 mg/m(2) every 3 weeks for three cycles) in reducing tumor burden in operable breast cancer >or=2.5 cm in largest diameter at diagnosis and its effect on the rate of conservative surgery. PATIENTS AND METHODS A total of 319 eligible patients, who were all candidates for mastectomy, were enrolled on to a multicenter prosp...